Authors:
Menendez, R
Stanford, RH
Edwards, L
Kalberg, C
Rickard, K
Citation: R. Menendez et al., Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma, PHARMACOECO, 19(8), 2001, pp. 865-874
Authors:
Calhoun, WJ
Nelson, HS
Nathan, RA
Pepsin, PJ
Kalberg, C
Emmett, A
Rickard, KA
Dorinsky, P
Citation: Wj. Calhoun et al., Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone, AM J R CRIT, 164(5), 2001, pp. 759-763
Citation: J. Matz et al., Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations, J ALLERG CL, 107(5), 2001, pp. 783-789
Authors:
Busse, W
Raphael, GD
Galant, S
Kalberg, C
Goode-Sellers, S
Srebro, S
Edwards, L
Rickard, K
Citation: W. Busse et al., Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial, J ALLERG CL, 107(3), 2001, pp. 461-468
Citation: Ra. Nathan et al., A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma, AM J MED, 111(3), 2001, pp. 195-202
Authors:
Bleecker, ER
Welch, MJ
Weinstein, SF
Kalberg, C
Johnson, M
Edwards, L
Rickard, KA
Citation: Er. Bleecker et al., Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma, J ALLERG CL, 105(6), 2000, pp. 1123-1129
Authors:
Condemi, JJ
Goldstein, S
Kalberg, C
Yancey, S
Emmett, A
Rickard, K
Citation: Jj. Condemi et al., The addition of salmeterol to fluticasone propionate versus increasing thedose of fluticasone propionate in patients with persistent asthma, ANN ALLER A, 82(4), 1999, pp. 383-389
Authors:
Rosenthal, RR
Busse, WW
Kemp, JP
Baker, JW
Kalberg, C
Emmett, A
Rickard, KA
Citation: Rr. Rosenthal et al., Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness, CHEST, 116(3), 1999, pp. 595-602